Innate Pharma SA
Florent Carrette is an experienced professional in the field of research and development, currently serving as an R&D senior preclinical/translational lead and R&D project manager at Innate Pharma since March 2020. Prior to this role, Florent worked as a senior scientist in R&D at the same company. Earlier experience includes a position as a postdoctoral research fellow at CIML from August 2018 to March 2020 and roles at Sanford-Burnham Medical Research Institute and The Scripps Research Institute from April 2012 to March 2012, respectively. Florent holds a PhD from Pierre and Marie Curie University.
This person is not in any teams
This person is not in any offices
Innate Pharma SA
2 followers
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.